Influenza vaccine immunology

Area of Science:

• Immunology
• Vaccinology
• Epidemiology

Background:

• Influenza virus spread and immunity are critical public health concerns.
• The 2009 H1N1 pandemic highlighted the importance of understanding influenza protection.
• Antibodies targeting hemagglutinin are key for protection against seasonal and pandemic influenza strains.

Purpose of the Study:

• To analyze the mechanisms of influenza immunity and vaccine-induced protection.
• To evaluate the impact of prior exposure (priming) on immune responses to influenza.
• To compare the efficacy of different influenza vaccine types and adjuvants.

Main Methods:

• Review of studies on influenza spread, immunity, and vaccine effectiveness.
• Analysis of antibody responses (neutralizing, receptor-blocking) to hemagglutinin and neuraminidase.
• Comparison of inactivated, live attenuated, and adjuvanted influenza vaccines.

Main Results:

• Neutralizing and receptor-blocking antibodies against hemagglutinin are primary protective mechanisms.
• Prior exposure (priming) is more critical for effective immunization than original antigenic sin.
• Both live attenuated and inactivated vaccines offer protection, with specific advantages for certain populations.
• Adjuvanted inactivated vaccines enhance antibody responses, broaden cross-reactivity, and allow dose-sparing.

Conclusions:

• Immunity against influenza is complex, involving various antibody types and prior exposures.
• Vaccine strategies should prioritize priming for robust and broad protection.
• Adjuvants can significantly improve the immunogenicity and breadth of influenza vaccines.